Improving stem cell therapy delivery for heart repair
Drug Delivery and Biomimetic Approaches for Optimal Stem Cell Therapy
This study is looking at a new way to help the heart heal after injury by using tiny particles that act like platelets to deliver healing factors directly to the heart, making stem cell therapy more effective without needing invasive procedures.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia Univ New York Morningside NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10806948 on NIH RePORTER |
What this research studies
This research focuses on enhancing the delivery of stem cell factors to the heart to promote healing after injury. It addresses two main challenges: the rapid diffusion of injected growth factors and the need for targeted delivery without invasive procedures. The approach involves creating a novel nanoparticle that mimics platelets, allowing for sustained release of therapeutic factors directly to the heart. This method aims to improve the effectiveness of stem cell therapy in cardiac regeneration.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with heart injuries or conditions that could benefit from enhanced stem cell therapy.
Not a fit: Patients with stable heart conditions that do not require regenerative therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for heart injuries, improving recovery and reducing complications.
How similar studies have performed: Other research has shown promise in using biomimetic approaches for drug delivery, indicating potential success for this novel method.
Where this research is happening
New York, United States
- Columbia Univ New York Morningside — New York, United States (Active)
Researchers
- Principal investigator: Cheng, Ke — Columbia Univ New York Morningside
- Study coordinator: Cheng, Ke
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.